US allows emergency use of first COVID-19 antibody drug

The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data showing that a one-time infusion of the treatment reduced the need for hospitalization or emergency room visits in high-risk COVID-19 patients.

from News-Economic Times https://ift.tt/32sXIR7